FMR LLC 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Turning Point Therapeutics, Inc. TPTX | FMR LLC | 1,398,602 2.826% | -1,775,067 (-55.93%) | Filing |
| 2021-06-10 11:37 am Sale | 2021-06-09 | 13G | Turning Point Therapeutics, Inc. TPTX | FMR LLC | 3,173,669 6.456% | -3,041,693 (-48.94%) | Filing |
| 2021-02-08 10:35 am Purchase | 2021-02-05 | 13G | Turning Point Therapeutics, Inc. TPTX | FMR LLC | 6,215,362 12.902% | 1,374,716 (+28.40%) | Filing |